Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
about
Early life programming as a target for prevention of child and adolescent mental disordersPharmacotherapy of obsessive-compulsive disorder during pregnancy: a clinical approachContributions of a Child's Built, Natural, and Social Environments to Their General Cognitive Ability: A Systematic Scoping ReviewCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersPharmacotherapy of postpartum depression: an updateA patient decision aid for antidepressant use in pregnancy: study protocol for a randomized controlled trial.The Quebec Pregnancy Cohort--prevalence of medication use during gestation and pregnancy outcomesRate of Chiari I malformation in children of mothers with depression with and without prenatal SSRI exposure.Management of postpartum depression.Links between serotonin reuptake inhibition during pregnancy and neurodevelopmental delay/spectrum disorders: A systematic review of epidemiological and physiological evidence.Antidepressant use in pregnant and postpartum womenAssociation Between Antidepressants Use During Pregnancy and Autistic Spectrum Disorders: A Meta-analysis.Genome-wide DNA methylation in neonates exposed to maternal depression, anxiety, or SSRI medication during pregnancy.Treatment of nonpsychotic major depression during pregnancy: patient safety and challengesNeurodevelopmental outcome for offspring of women treated for antenatal depression: a systematic reviewDisparities in antidepressant use in pregnancy.Behavioural effects of fetal antidepressant exposure in a Norwegian cohort of discordant siblingsAre female children more vulnerable to the long-term effects of maternal depression during pregnancy?Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study.Assessing the Independent and Joint Effects of Unmedicated Prenatal Depressive Symptoms and Alcohol Consumption in Pregnancy and Infant Neurodevelopmental Outcomes.Maternal psychological distress in primary care and association with child behavioural outcomes at age threeOf rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research.Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly.Selective serotonin reuptake inhibitors and pregnancy: A review of maternal, fetal and neonatal risks and benefits.Antidepressant exposure in pregnancy and risk of autism spectrum disorders.Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.Use of psychotropic medication during pregnancy and the postpartum period.Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review.Prenatal SSRI exposure: Effects on later child development.Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence.A pharmacological approach to panic disorder during pregnancy.Does maternal mental well-being in pregnancy impact the early human epigenome?Depression and Anxiety During Pregnancy: Evaluating the Literature in Support of Clinical Risk-Benefit Decision-Making.Use of Antidepressants During Pregnancy?: What to Consider when Weighing Treatment with Antidepressants Against Untreated Depression.Child developmental outcomes in preschool children following antidepressant exposure in pregnancy.A role for the serotonin reuptake transporter in the brain and intestinal features of autism spectrum disorders and developmental antidepressant exposure.Prenatal antidepressant exposure and child behavioural outcomes at 7 years of age: a study within the Danish National Birth Cohort.Prenatal exposure to selective serotonin reuptake inhibitors and non-verbal cognitive functioning in childhood.Antenatal depression, treatment with selective serotonin reuptake inhibitors, and neonatal brain structure: A propensity-matched cohort study.Managing depression during pregnancy.
P2860
Q21245282-F3DE6188-560B-48C6-BAB7-87464E9AA32EQ26774013-52AA9AC2-8102-41CE-ADEC-574CDAAA8DC8Q26996076-F88770F9-125C-404E-A3A0-B4F3C7483D8BQ27009995-A7F82349-55D2-4F0A-BC74-046E0B947CF6Q27010062-852FC928-5BF7-4201-93FE-54140060A63CQ27334448-EE78DA09-C69A-42FC-B909-70CE53B6A947Q28542006-19321706-0D8E-422F-9239-925C194EF43CQ30595737-3784A0D1-80A6-47E3-B2FF-7EDCA255E8FCQ33914618-7C2D0338-5175-4B40-8E2A-A03D54977E0DQ34047430-7968A5A6-4580-4C3B-8320-7CB18D99B9BCQ34068023-BE1AF25E-460F-42F6-B15A-A6FAC6824EB7Q34075005-BED8B3DD-66F8-4C7B-8948-7AF54FC631D3Q34084274-A9FF43D7-883F-41E1-BC44-475E99C859CCQ34237681-5D0046D5-6633-433C-B076-E420251C1CE3Q34544981-0F4D469A-11E5-4B99-9BB6-424E53822F40Q35236020-DE38E468-14E9-4542-9E83-429ECFFDD1C6Q36107667-9B65A30B-5D25-4542-BDB9-804F0CC3D977Q36294597-42BEE1CC-8F55-4DE2-BE98-EB3EB326D248Q36853542-ADEA9BB9-63ED-45B6-BB0E-6F33B9EFD5C8Q36957730-051DF71E-DD28-441F-B22D-3FEAFC3B8DFDQ36958098-ADDDD3A3-D186-4B5A-9732-66BA959E2F7FQ37058701-F3442F9D-7501-4B6F-9D8A-F17D01297E00Q37197207-8D6D8D2C-CB29-4FF4-B2BD-E34FCC85006CQ37216136-D2D54524-139A-4C79-997B-DFA4DDA38104Q37320948-90477012-31A3-434C-A5B2-333DD0475981Q37337705-2CFC65F0-4828-427B-80BE-0A36E4D94E45Q38155675-438507FD-5046-471B-814F-F53A9D7991D2Q38215072-68DA725E-15B0-4C77-BD1E-DD9342FE50EFQ38236646-ED6DD7E4-BFE9-4D31-8DF2-C64657373504Q38305749-92ED23BD-8FE1-4246-B0EE-B03F5B38D3B9Q38516009-16D211B6-9A16-4FCD-AD89-927EEF21E636Q38763849-F8124D05-A556-44D0-A75D-5FD10E12B248Q38811512-554A48FD-5BD0-4BAC-A3BA-7A5E2D2F5816Q38909371-F4B7F5EE-2EC7-45F6-B460-836BC9ADCE58Q39037107-6DFC9C66-5A3F-434F-9217-03E52C632426Q39141290-7F13D552-65FF-4270-BA83-4855CD594D88Q40535696-6D4A698F-C6C4-4C9A-86F2-03076AD662A6Q40583260-2F617AF8-24BB-41A8-8C6A-D26EFE48FCACQ42444090-A596D0F9-60E9-4DE7-8E72-FADCD2DB2978Q43451478-FB46D8AE-ECE3-4B21-BCB0-E564752AA8E1
P2860
Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Neurodevelopment of children f ...... untreated maternal depression.
@en
Neurodevelopment of children f ...... untreated maternal depression.
@nl
type
label
Neurodevelopment of children f ...... untreated maternal depression.
@en
Neurodevelopment of children f ...... untreated maternal depression.
@nl
prefLabel
Neurodevelopment of children f ...... untreated maternal depression.
@en
Neurodevelopment of children f ...... untreated maternal depression.
@nl
P2093
P1476
Neurodevelopment of children f ...... untreated maternal depression.
@en
P2093
Ariel Pulver
Brian Feldman
Gideon Koren
Irena Nulman
Joanne Rovet
P304
P356
10.1176/APPI.AJP.2012.11111721
P407
P577
2012-11-01T00:00:00Z